U.S, MARIJUANA BUSINESS DAILY (20 June 21) Recreational marijuana makes the most headlines, but a large number of cannabis consumers buy and use the plant for medical and wellness reasons.
These include acute medical conditions such as cancer, chronic pain and epilepsy, as well...
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
U.S, February 12, 2020 (CANNABISTECH) Solving bioavailability issues with cannabinoids, nanoemulsion technology and ultrasonic techniques increase product effectiveness.
Cannabis has always had an issue with bioavailability. Whether smoked, eaten, or applied, each method of delivery loses a significant percentage of medicinal or...
U.S, December 21, 2019 (INDEPENDENT) Thousands of people with severe epilepsy will be able to access a cannabis-based treatment on the NHS from the new year, it has been revealed.
Epidyolex, a cannabidiol (CBD) oral medication, has been fast-tracked by the health service in England to be available from 6...
U.S, January 28, 2020 (MARIJUANABUSINESS) The marijuana industry’s largest trade association released a report Tuesday on the vaping health scare that calls on cannabis business owners, regulators and law enforcement to do more to combat the illegal market.
The National Cannabis Industry Association (NCIA) report targets several areas for...
U.S, January 20, 2020 (ANALYTICALCANNABIS) Marijuana use is rising among US patients with cardiovascular disease, researchers have warned.
Published in the Journal of the American College of Cardiology today, a new review article has estimated that 2 million US marijuana users were living with cardiovascular...